Pakistan joins 52 countries on Covid-19 research, development

Published August 27, 2021
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. —  AFP/File
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. — AFP/File

ISLAMABAD: Pakistan has enrolled to participate in the ‘Solidarity PLUS’ clinical trial led by the World Health Organisation (WHO) that will evaluate three potential drugs — artesunate, imatinib and infliximab — for the treatment of Covid-19 infections aiming to protect people from severe hospitalisation and death because of the pandemic.

WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study, making up the largest global collaboration on Covid-19 research and development.

The three potential drugs were selected by a panel of experts who assess all available evidence on relevant therapeutics. The drugs have proven effectiveness in treating other life-threatening diseases. Artesunate is used for severe malaria, imatinib for specific cancers, and infliximab for diseases of the immune system, such as Crohn’s disease and rheumatoid arthritis.

“Covid-19 has been the most disruptive public health challenge in the past century. In less than two years, the pandemic has claimed over 4.4 million lives across the world, overwhelmed health systems, and disrupted economies and societies.

“It is critical that we find effective treatments to prevent severe hospitalisation and death caused by Covid-19. We appreciate the efforts of countries in the region in collaborating on vital global studies for the treatment of Covid-19, in the spirit of solidarity,” said Dr Ahmed Al-Mandhari, WHO Regi­onal Director for the Eastern Mediterranean.

Published in Dawn, August 27th, 2021

Opinion

Editorial

Banning PTI
Updated 16 Jul, 2024

Banning PTI

It appears that the govt and its backers within the establishment have still not realised that they are in uncharted territory.
Nato at 75
16 Jul, 2024

Nato at 75

EMERGING from the ashes of World War II, and locked in confrontation with the Soviet-led Communist bloc for over ...
Non-stop massacres
16 Jul, 2024

Non-stop massacres

Netanyahu is cunningly pretending to talk peace while mercilessly pounding Gaza. What is clear is that a return to pre-Oct 7 status quo is impossible.
Afghan challenge
Updated 15 Jul, 2024

Afghan challenge

Foreign states must emphasise to the Afghan Taliban diplomatic recognition and trade relations all depend on greater counterterrorism efforts.
‘Complete’ justice
15 Jul, 2024

‘Complete’ justice

NOW that the matter of PTI’s reserved seats stands resolved, there are several equally pressing issues pertaining...
Drug fog
15 Jul, 2024

Drug fog

THE country has an old drug problem. While the menace has raged across divides of class and gender, successive ...